Liberum is pleased to announce that it acted as Joint Bookrunner in relation to a 5% placing of Genus Plc’s issued share capital, raising £68 million.
Genus, a FTSE 250 company, is a world-leading animal genetics company headquartered in the UK. The Company continuously develops higher quality pigs and cows for farmers, by selecting animals with desirable characteristics that help them to produce higher quality meat and milk more sustainably.
Net proceeds will be applied to reduce the Company’s net debt position (£108.5m at 30 June 2018), following a series of acquisitions and capex investments in recent years, and to provide balance sheet flexibility to continue to capture growth opportunities.
Management see continued opportunities to strengthen and grow the Genus business further through acquisition and business development transactions. Following the placing, the
net debt/EBITDA is expected to be in the
region of 1.0x.
Investment Banking – Clayton Bush, Josh Hughes, Trystan Cullen, Laura Hamilton
Sales – David Parsons, Julian Collett
Research – Sophie Jourdier
Corporate Access – Lynsey Cox, Natalie Clarke
Liberum is pleased to announce that it acted as Financial Adviser, Nominated Adviser and Sole Bookrunner in relation to a placing & acquisition by Science in Sport plc, raising £29 million. The placing part funded the acquisition of PhD Nutrition Ltd for a total consideration of £32 million.
Science in Sport plc, a UK-headquartered market leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts.
PhD is a UK-headquartered premium protein brand, which has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.
The deal doubles the size of the Company and accelerates their ambition to become a global leader in premium performance nutrition. SIS and PhD are two businesses that have complementary brands, products, operations and sales channels which together create a well-balanced, cash generative company with enhanced potential.
Investment Banking – Clayton Bush, Chris Clarke, James Greenwood, William Hall, Stephanie Poulier
Sales – Oliver Baxendale, Julian Collett, Gerard O’Doherty, Sebastian Fernandez
Research – Wayne Brown, Tom Musson
Corporate Access – Marcio Remedios
Liberum is pleased to announce its appointment as Joint Corporate Broker to TruFin plc (“TruFin”).
TruFin is the holding company of an operatinggroup comprising three growth-focused FinTech and banking businesses operating in three niche lending markets: DF Capital (supply chain finance), Satago (invoice finance) and Oxygen Finance (dynamic discounting).
In addition, TruFin owns a c.13% minority stake in Zopa, a leading UK consumer P2P lender, which operates independently of TruFin.
TruFin was established through a series of acquisitions and investments by Arrowgrass between 2014 and 2017 and completed an AIM IPO in February 2018. It currently has 100 employees with offices in the UK and a small team in the US.
Liberum has been appointed as Joint Corporate Broker with immediate effect. Macquarie acts as TruFin’s Nominated Adviser and Joint Corporate Broker.
Investment Banking - Chris Clarke, Trystan Cullen, Louis Davies, Stephanie Poulier
Sales - Julian Collett, Steve Keeling
Research - Ben Williams, Jamie Donald
Corporate Access - Lynsey Cox
We are pleased to announce that Liberum has been appointed as Joint Corporate Broker to SolGold plc. SolGold is a copper gold exploration company focussed in Ecuador.
The company has discovered a world class copper/gold porphyry on its flagship Cascabel licence in Northern Ecuador containing 5.3mt of copper and 12.3moz of gold as at December 2017. Continued exploration success implies this resource will grow significantly.
SolGold is the largest tenement holder in Ecuador and has the most active exploration programme in country. It plans to apply its successful porphyry exploration blueprint across the country, where it employs more than 80 geologists.
Ecuador’s underexplored status, along with a consenually positive long-term copper market outlook amongst major mining companies present SolGold with an opportunity to grow into an explorer, developer and miner of global significance.
The Company listed on London's AIM Market in 2006, and dual-listed onto the Toronto Stock Exchange in July 2017. The Company was admitted to the Main Market (Standard Listing) of the London Stock Exchange in October 2017 (at which point it ceased
to trade on AIM).
Liberum has been appointed as Joint Corporate Broker with immediate effect.
Investment Banking – Clayton Bush, Trystan Cullen, Laura Hamilton
Research – Richard Knights
Sales – Julian Collett
Corporate Access – Lynsey Cox
Liberum is pleased to announce that it is acting as Corporate Broker to Communisis plc in connection with its recommended cash offer by Output Services Group, Inc.
Communisis is an integrated business services company that provides digitally enabled solutions for regulated communication and marketing execution. On 23 October, Communisis announced it was recommending an offer by Output Services Group, a US based omnichannel billing company.
The offer price of 71 pence per share represents:
Liberum helped deliver irrevocable undertakings and LOIs from Communisis shareholders that represented c.43% of the register.
Investment Banking – Neil Patel, Cameron Duncan, Jonathan Wilkes-Green
We are pleased to announce that Liberum has been appointed as Corporate Broker to GetBusy plc.
GetBusy plc is a document management software company with operations in UK, USA, Australia and New Zealand.
GetBusy has two core product offerings:
In August 2017, GetBusy demerged from ASX listed Reckon an Australian software company and admitted to trading on AIM. As at 30 June 2018, the company had annualised monthly recurring revenue of £9.4m.
Liberum has been appointed as Sole Corporate Broker with immediate effect.
Investment Banking – Bidhi Bhoma, Cameron Duncan, Louis Davies
Research – Andrew Bryant
Sales – Oliver Baxendale
Corporate Access – Marcio Remedios
Press Enquiries: Redleaf Polhill